CMMB Q2 2018 Earnings — Chemomab Therapeutics Ltd. Revenue & Financial Results | Market Cap Arena

CMMBChemomab Therapeutics Ltd.

$12M

Q2 2018 Earnings

Revenue

Gross Profit

-$17,325

Operating Income

-$4M

Net Income

-$5M

EPS (Diluted)

$-43.52

QoQ Revenue Growth

NaN%

Metric	Current	Year Ago	Change
Revenue	$0	$0	—
Gross Profit	-$17,325	-$10,426	-66.2%
Operating Income	-$4M	-$4M	-14.4%
Net Income	-$5M	-$4M	-42.9%